PLX3397: Clinical Trials

1 trial of PLX3397, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow PLX3397: new trials by email Literature Review of PLX3397 trials Research Report on PLX3397

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
PLX3397 - Melanoma
Not applicableCompletedDaiichi Sankyo Co., Ltd.62017-01-312026-01-13

Conditions studied

Melanoma (1)

Sponsors

Daiichi Sankyo Co., Ltd. (1)

Countries

China (1)  ·  South Korea (1)